{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T08:09:37Z","timestamp":1785658177800,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.numecd.2025.104478","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:52:36Z","timestamp":1764291156000},"page":"104478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlated factors and prognostic importance of reduction in liver stiffness measurement in individuals with type 2 diabetes and MASLD"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-0153","authenticated-orcid":false,"given":"Claudia R.L.","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane A.","family":"Villela-Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil F.","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie C.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.numecd.2025.104478_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.amjmed.2020.01.007","article-title":"Nonalcoholic fatty liver disease: what does the primary care physician need to know?","volume":"133","author":"Budd","year":"2020","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.numecd.2025.104478_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1478-3231.2011.02482.x","article-title":"Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors","volume":"31","author":"Leite","year":"2011","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.numecd.2025.104478_bib5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ajg.2014.132","article-title":"Mortality from chronic liver diseases in diabetes","volume":"109","author":"Zoppini","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1053\/j.gastro.2023.06.030","article-title":"Dynamics in liver stiffness measurements predict outcomes in advanced chronic liver disease","volume":"165","author":"Semmler","year":"2023","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cgh.2020.06.045","article-title":"Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease","volume":"19","author":"Petta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2024.05.008","article-title":"Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD","volume":"81","author":"Gawrieh","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104478_bib10","author":"Leite","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.numecd.2025.104478_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2025.104478_bib12","article-title":"Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: a prospective multicenter study","author":"Huang","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.numecd.2025.104478_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12933-021-01388-2","article-title":"Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study","volume":"20","author":"Cardoso","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.numecd.2025.104478_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107879","article-title":"Importance of non-invasive liver fibrosis scores for mortality and complications development in individuals with type 2 diabetes","volume":"35","author":"Leite","year":"2021","journal-title":"J Diabet Complicat"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/liv.15845","article-title":"Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus","volume":"44","author":"Lavrado","year":"2024","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.numecd.2025.104478_bib16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/oby.24035","article-title":"Body weight variability and the risk of liver-related outcomes in type 2 diabetes and steatotic liver disease: a cohort study","volume":"32","author":"Leite","year":"2024","journal-title":"Obesity"},{"key":"10.1016\/j.numecd.2025.104478_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110191","article-title":"The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study","volume":"194","author":"Park","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.numecd.2025.104478_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.numecd.2025.104478_bib19","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1136\/gutjnl-2024-333074","article-title":"Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease","volume":"73","author":"Zhou","year":"2024","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib20","article-title":"Statin use and liver-related prognosis among patients with MASLD","volume":"7","author":"Yun","year":"2024","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.numecd.2025.104478_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101816","article-title":"Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: a systematic review and meta-analysis","volume":"46","author":"Fatima","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"11","key":"10.1016\/j.numecd.2025.104478_bib22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.amjmed.2024.06.031","article-title":"Modifiable risk factors for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease: a meta-analysis","volume":"137","author":"Xiao","year":"2024","journal-title":"Am J Med"},{"key":"10.1016\/j.numecd.2025.104478_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104392","article-title":"Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study","volume":"87","author":"Ayada","year":"2023","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.numecd.2025.104478_bib24","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1053\/j.gastro.2009.01.053","article-title":"Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes","volume":"136","author":"El-Serag","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2025.104478_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154752","article-title":"Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes","volume":"121","author":"Ciardullo","year":"2021","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.numecd.2025.104478_bib26","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/liv.15656","article-title":"Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM","volume":"43","author":"Wu","year":"2023","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.numecd.2025.104478_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1186\/s12885-025-14299-2","article-title":"Statin use and risk of HCC in patients with MASLD and T2DM: an umbrella review and meta-analysis","volume":"25","author":"Hosseinkhan","year":"2025","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.numecd.2025.104478_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.numecd.2025.104478_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16133","article-title":"Impact of PNPLA3 I148M on clinical outcomes in patients with MASLD","volume":"45","author":"Petta","year":"2025","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.numecd.2025.104478_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.numecd.2025.104478_bib31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cgh.2021.05.056","article-title":"A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores","volume":"20","author":"De Vincentis","year":"2022","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325006337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325006337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:10:48Z","timestamp":1773958248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325006337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0939475325006337"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104478","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlated factors and prognostic importance of reduction in liver stiffness measurement in individuals with type 2 diabetes and MASLD","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104478"}}